Aparajita Lath Biotechnology Health Law Policy Intellectual Property International Pharmaceuticals Public Health Resource Allocation Student Fellows Vaccines Accessing COVID-19 mRNA Vaccines for Research: The Re-emergence of the Tragedy of the ‘Anticommons’ Read more: Accessing COVID-19 mRNA Vaccines for Research: The Re-emergence of the Tragedy of the ‘Anticommons’
Contributors FDA Health Law Policy Human Subjects Research Immunization Jacob Sherkow Nicholson Price Pharmaceuticals Public Health Rachel Sachs Scientific Evidence Vaccines Why Do Differences in Clinical Trial Design Make It Hard to Compare COVID-19 Vaccines? Read more: Why Do Differences in Clinical Trial Design Make It Hard to Compare COVID-19 Vaccines?
Contributors FDA Health Law Policy Jacob Sherkow Nicholson Price Pharmaceuticals Public Health Rachel Sachs Vaccines What’s the Difference Between Vaccine Approval (BLA) and Authorization (EUA)? Read more: What’s the Difference Between Vaccine Approval (BLA) and Authorization (EUA)?
Contributors FDA Health Law Policy Jacob Sherkow Nicholson Price Patient Care Pharmaceuticals Public Health Rachel Sachs Vaccines How Can Policymakers Overcome the Hurdles to Scaling up Antibody Manufacturing? Read more: How Can Policymakers Overcome the Hurdles to Scaling up Antibody Manufacturing?
Contributors FDA Health Law Policy Jacob Sherkow Nicholson Price Patient Care Pharmaceuticals Public Health Rachel Sachs Vaccines Why Aren’t Therapeutic Antibodies Being Used More to Treat COVID-19? Read more: Why Aren’t Therapeutic Antibodies Being Used More to Treat COVID-19?
Contributors FDA Health Law Policy Jacob Sherkow Nicholson Price Patient Care Pharmaceuticals Public Health Rachel Sachs Vaccines What Can Policymakers Learn from the Slow COVID-19 Vaccine Rollout? Read more: What Can Policymakers Learn from the Slow COVID-19 Vaccine Rollout?
Featured Health Law Policy Judicial Opinions Off-Label Use Pediatrics Pharmaceuticals Public Health Race Scientific Evidence Social Determinants of Health Vaccines Can Schools Require the COVID-19 Vaccine? Education, Equity, and the Courts Read more: Can Schools Require the COVID-19 Vaccine? Education, Equity, and the Courts
Contributors FDA Health Law Policy Human Subjects Research Jacob Sherkow Nicholson Price Patient Care Pharmaceuticals Public Health Rachel Sachs Scientific Evidence Vaccines How Can Policymakers Encourage COVID-19 Vaccine Trials for Children? Read more: How Can Policymakers Encourage COVID-19 Vaccine Trials for Children?
Contributors FDA Health Law Policy Human Subjects Research Intellectual Property Jacob Sherkow Nicholson Price Patient Care Pharmaceuticals Public Health Rachel Sachs Scientific Evidence Vaccines How are COVID-19 Vaccine Manufacturers Building Trust in the FDA’s Approval Process? Read more: How are COVID-19 Vaccine Manufacturers Building Trust in the FDA’s Approval Process?
Contributors FDA Health Law Policy Human Subjects Research Intellectual Property Jacob Sherkow Nicholson Price Patient Care Pharmaceuticals Public Health Rachel Sachs Scientific Evidence Vaccines How Does Moderna’s COVID-19 Vaccine Work, and Who Is Funding Its Development? Read more: How Does Moderna’s COVID-19 Vaccine Work, and Who Is Funding Its Development?